Bone mineral density in HIV participants randomized to raltegravir and lopinavirritonavir compared with standard second line therapy

التفاصيل البيبلوغرافية
العنوان: Bone mineral density in HIV participants randomized to raltegravir and lopinavirritonavir compared with standard second line therapy
المؤلفون: Martin, Allison, Moore, Cecilia, Mallon, Patrick W.G., Hoy, Jennifer, Emery, Sean, Belloso, Waldo, Phanuphak, Praphan, Ferret, Samuel, Cooper, David A., Boyd, Mark A.
المصدر: AIDS; September 2013, Vol. 27 Issue: 15 p2403-2411, 9p
مستخلص: To compare changes over 48 weeks in bone mineral density (BMD) between participants randomized to lopinavirritonavir (LPVr)raltegravir (RAL) or LPVr 2–3nucleosidenucleotide reverse transcriptase inhibitors (N(t)RTIs) as second line therapy.
قاعدة البيانات: Supplemental Index
الوصف
تدمد:02699370
14735571
DOI:10.1097/01.aids.0000432534.47217.b4